Concepedia

Elias Bardouniotis

EB

Statistics

Publications

6

Citations

343

H-Index

6

Active since

2001

Affiliations

Monsanto (Canada)(Current)

University of Calgary

Elias Bardouniotis is an author at Monsanto (Canada) specializing in medicine, clinical microbiology, and drug discovery.

Top concepts

Publications per year

2001–2013

6

Publications

6

Mode of Action, <i>In Vitro</i> Activity, and <i>In Vivo</i> Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor

Nachum Kaplan, Monique Albert, Donald E. Awrey et al. · Antimicrobial Agents and Chemotherapy · 2012 · 109 citations · Full text

Biofilm Formation and Biocide Susceptibility Testing of Mycobacterium fortuitum and Mycobacterium marinum

Elias Bardouniotis, Howard Ceri, Merle S. Olson · Current Microbiology · 2002 · 95 citations

, , +9

Characterization of biofilm growth and biocide susceptibility testing of<i>Mycobacterium phlei</i>using the MBEC⢠assay system

Elias Bardouniotis, William Ryan Huddleston, Howard Ceri et al. · FEMS Microbiology Letters · 2001 · 57 citations · Full text

<i>In vitro</i>activity (MICs and rate of kill) of AFN-1252, a novel FabI inhibitor, in the presence of serum and in combination with other antibiotics

Nachum Kaplan, Donald E. Awrey, Elias Bardouniotis et al. · Journal of Chemotherapy · 2013 · 31 citations · Full text

2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabI

Jailall Ramnauth, Mathew D. Surman, Peter B. Sampson et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text

, , +8

1–5 of 6